The Role of Checkpoint inhibitors in CIA
检查点抑制剂在 CIA 中的作用
基本信息
- 批准号:10319910
- 负责人:
- 金额:$ 4.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectArthritisAutoimmune DiseasesBone MarrowCD3 AntigensCD8-Positive T-LymphocytesCD8B1 geneCSF1R geneCTLA4 geneCellsCessation of lifeChimera organismCollagen ArthritisDataDiseaseFemurFrequenciesHarvestHomeostasisHumanImmuneImmune checkpoint inhibitorInflammationInflammatory ArthritisJointsKnee jointKnockout MiceLinkMusMyeloid CellsOperative Surgical ProceduresPTPRC geneParabiosisPathogenesisPathway interactionsPatientsPeripheralPhenotypePlayPopulationRecoveryRegulationRheumatoid ArthritisRoleSeveritiesSynovial FluidSynovitisSystemT memory cellT-LymphocyteTechniquesTestingTherapeuticTissuesanti-CTLA4anti-PD-1anti-PD-L1cell stromadisabilityexperimental studyimmune checkpointimmune-related adverse eventsinhibitor/antagonistjoint inflammationmacrophagemouse modelnovelprematureprogrammed cell death ligand 1programmed cell death protein 1tibia
项目摘要
Abstract
Immune related adverse events linked to severe inflammatory arthritis have been identified in 10-43% of patients
receiving immune checkpoint inhibitors, αCTLA4, αPD-1 or αPD-L1, indicating the importance of immune
inhibitory pathways in maintaining homeostasis in the joints. We obtained human synovial fluid and found a high
frequency of PD-L1 expression by synovial macrophages. We propose to examine the role of PD-L1 expression
in synovial macrophages and T cells during murine collagen induced arthritis (CIA). We found that immune
checkpoint inhibitor, PD-L1, is primarily expressed in the joint compared to other immune checkpoints.
Additionally, we found synovial macrophages and CD3+ T cells are the main PD-L1 expressing cells in the joint,
and PD-L1 expression is increased during CIA. We extensively profiled the synovial macrophages and found
three populations of PD-L1 expressing cells: F4/80intCD115+CCR2-MHCII-CD73-Tim4-PD-L1hi (CD115+
macrophages), F4/80hiCD115-CCR2intMHCIIhiCD73intTim4intPD-L1int (MHCII+ macrophages), and F4/80intCD115-
CCR2lowMHCII-CD73loTim4intPD-L1int (F4/80+ macrophages). We have also found that PD-L1 has the highest
frequency of expression in CD4+ and CD8+ T cells. Furthermore, we identified a novel subset of joint tissue
resident memory T cells in the naïve joint that are phenotypically CD8+CD69+ and CD8+CD69+CD103+. We
hypothesize that the expression of PD-L1 by macrophages and/or T cells are essential for synovial
homeostasis and regulation of joint inflammation. In Aim 1, we will examine the importance of PD-L1
expression by synovial macrophages through the selective deletion of PD-L1 using the cre/flox system. We will
generate two macrophages specific PD-L1 KO mice, LyzcrePD-L1fl/fl and CD115crePD-L1fl/fl. We will induce CIA in
LyzcrePD-L1fl/fl, CD115crePD-L1fl/fl, Lyzcre and CD115cre mice and harvest the joint to determine the protective role
of synovial macrophage PD-L1 expression in CIA (Subaim 1.1). We will also perform parabiosis experiments by
surgically joining CD45.1 C57BL6 and CD45.2 CD115crePD-L1fl/fl to determine if PD-L1+ synovial macrophages
are resident or bone marrow derived during CIA (Subaim 1.2). We have found that PD-L1 is highly expressed
in synovial T cells. In Aim 2, we will examine the protective function of synovial T cells following CIA. We will use
LckcreP D-L1fl/fl mice, which lack PD-L1 expression in CD3+ T cells to examine the effects of PD-L1 specific
deletion in T cells during CIA (Subaim 2.1). To test if tissue resident memory T cells play a protective role during
CIA, we will utilize a tissue resident chimera mouse model to selectively delete peripheral T cells in LckcrePD-
L1fl/fl mice. Donor T cells from LckcrePD-L1fl/fl or Lckcre mice will replace peripheral T cell populations to confirm
the protective function of tissue resident memory T cells in the joint (Subaim 2.2). Our project has high
translational potential since joint specific PD-L1 expression could be modulated with therapeutic purposes in
humans for rheumatoid arthritis or check point inhibitors induced arthritis.
摘要
在10%-43%的患者中发现了与严重炎症性关节炎有关的免疫相关不良事件
接受免疫检查点抑制剂,αCTLA4,αPD-1或αPD-L1,表明免疫的重要性
维持关节内动态平衡的抑制途径。我们提取了人体滑液,发现高密度
滑膜巨噬细胞表达PD-L1的频率。我们建议研究PD-L1表达的作用
在小鼠胶原性关节炎(CIA)过程中滑膜巨噬细胞和T细胞的表达。我们发现这种免疫力
与其他免疫检查点相比,检查点抑制因子PD-L1主要在关节中表达。
此外,我们还发现滑膜巨噬细胞和CD3+T细胞是关节中表达PD-L1的主要细胞,
在CIA过程中,PD-L1的表达增加。我们对滑膜巨噬细胞进行了广泛的分析,发现
三种PD-L1表达细胞:F4/80intCD115+CCR2-MHCII-CD73-Tim4-PD-L1hi(CD115+
巨噬细胞)、F4/80hiCD115-CCR2intMHCIIhiCD73intTim4intPD-L1int(巨噬细胞)和F4/80intCD115-
CCR2lowMHCII-CD73loTim4intPD-L1int(F4/80+巨噬细胞)。我们还发现PD-L1具有最高的
在CD4+和CD8+T细胞中的表达频率。此外,我们还鉴定了一个新的关节组织亚群。
幼稚关节内的常驻记忆T细胞,表型为CD8+CD69+和CD8+CD69+CD103+。我们
假设巨噬细胞和/或T细胞表达PD-L1对滑膜是必需的
关节炎症的动态平衡和调节。在目标1中,我们将检查PD-L1的重要性
滑膜巨噬细胞通过使用cre/flx系统选择性删除PD-L1表达。我们会
建立巨噬细胞特异性PD-L1KO小鼠LyzcrePD-L1fl/fl和CD115crePD-L1fl/fl。我们会诱使中情局
LyzcrePD-L1fl/fl、CD115crePD-L1fl/fl、Lyzcre和CD115cre小鼠,观察其对关节的保护作用
CIA滑膜巨噬细胞PD-L1的表达(Subaim 1.1)。我们还将通过以下方式进行异种繁殖实验
CD45.1 C57BL6和CD45.2 CD115crePD-L1fl/fl联合检测PD-L1+滑膜巨噬细胞
是中情局期间的常驻或骨髓来源(Subaim 1.2)。我们发现PD-L1高表达
在滑膜T细胞中。在目标2中,我们将研究CIA后滑膜T细胞的保护功能。我们将使用
Lockcrep D-L1fl/fl小鼠,在CD3+T细胞中缺乏PD-L1表达,以检测PD-L1特异性的影响
CIA期间T细胞的缺失(Subaim 2.1)。为了测试组织驻留记忆T细胞是否在
CIA,我们将利用组织驻留嵌合体小鼠模型选择性地删除LockcrePD-
L1fl/fl小鼠。来自LockcrePD-L1fl/fl或Lockcre小鼠的供体T细胞将取代外周T细胞群以证实
关节中组织驻留记忆T细胞的保护功能(Subaim 2.2)。我们的项目有很高的
由于关节特异性PD-L1的表达可以根据治疗目的进行调节,因此具有翻译潜力
人类用于类风湿性关节炎或检查点抑制剂引起的关节炎。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Megan Kay Wood其他文献
Megan Kay Wood的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Megan Kay Wood', 18)}}的其他基金
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
Tissue tropism of PD-1 therapy in ulcerative colitis and rheumatoid arthritis
PD-1治疗溃疡性结肠炎和类风湿性关节炎的组织向性
- 批准号:
MR/Y009681/1 - 财政年份:2024
- 资助金额:
$ 4.6万 - 项目类别:
Fellowship
Do autoantibodies to aberrantly glycosylated MUC1 drive extra-articular rheumatoid arthritis, and can GSK assets prevent driver antigen formation?
针对异常糖基化 MUC1 的自身抗体是否会导致关节外类风湿性关节炎,GSK 资产能否阻止驱动抗原形成?
- 批准号:
MR/Y022947/1 - 财政年份:2024
- 资助金额:
$ 4.6万 - 项目类别:
Research Grant
Preclinical development of an extracellular vesicle biotherapeutic for juvenile idiopathic arthritis
幼年特发性关节炎细胞外囊泡生物治疗药物的临床前开发
- 批准号:
10068495 - 财政年份:2024
- 资助金额:
$ 4.6万 - 项目类别:
Collaborative R&D
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 4.6万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Exploring the inflammatory mediators degraded by MMP-2 in MMP-2-deficient mice with knee arthritis through a novel TMT-TAILS quantitative proteomics
通过新型 TMT-TAILS 定量蛋白质组学探索 MMP-2 缺陷型膝关节炎小鼠中 MMP-2 降解的炎症介质
- 批准号:
24K19850 - 财政年份:2024
- 资助金额:
$ 4.6万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of an adaptive platform trial to prevent Rheumatoid Arthritis in partnership with First Nations People.
与原住民合作开发预防类风湿关节炎的适应性平台试验。
- 批准号:
491810 - 财政年份:2023
- 资助金额:
$ 4.6万 - 项目类别:
Operating Grants
The role of diet, as mediated by the gut microbiome, on childhood arthritis disease activity: a feasibility intervention study.
肠道微生物组介导的饮食对儿童关节炎疾病活动的作用:一项可行性干预研究。
- 批准号:
489316 - 财政年份:2023
- 资助金额:
$ 4.6万 - 项目类别:
Operating Grants
Investigation of hypoxia-inducible factor-1 (HIF-1) as a novel therapeutic target for juvenile idiopathic arthritis.
研究缺氧诱导因子-1 (HIF-1) 作为幼年特发性关节炎的新治疗靶点。
- 批准号:
23K14987 - 财政年份:2023
- 资助金额:
$ 4.6万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
DEMORA: DEep spatial characterization of synovial MacrOphages in Rheumatoid Arthritis
DEMORA:类风湿性关节炎滑膜巨噬细胞的深度空间特征
- 批准号:
EP/Y027760/1 - 财政年份:2023
- 资助金额:
$ 4.6万 - 项目类别:
Fellowship
The roles and mechanisms of inflammation resolution in the development of Rheumatoid Arthritis
炎症消退在类风湿关节炎发展中的作用和机制
- 批准号:
10733789 - 财政年份:2023
- 资助金额:
$ 4.6万 - 项目类别: